Anthrax edema toxin impairs clearance in mice

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 529-538

  Sastalla, Inka ^a   Tang, Shixing ^b   Crown, Devorah ^a   Liu, Shihui ^a   Eckhaus, Michael A ^c   Hewlett, Indira K ^b   Leppla, Stephen H ^a   Moayeri, Mahtab ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; ANTIGEN; AQUAPORIN 2; BIOTIN; EDEMA TOXIN; GREEN FLUORESCENT PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; OLIGOMER; OVALBUMIN; PROTECTIVE ANTIGEN; TUMOR ENDOTHELIAL MARKER 8; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHRAX; ANTIGEN BINDING; ARTICLE; BACTERIAL CLEARANCE; BONE MARROW CELL; CAPILLARY MORPHOGENESIS GENE 2; CIRCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEHYDRATION; ENDOCYTOSIS; FEMALE; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; INFECTION; KIDNEY; KIDNEY COLLECTING TUBULE; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TOXEMIA; UPREGULATION;

ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CHO CELLS; CRICETINAE; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, PEPTIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 84863127146     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05947-11     Document Type: Article

References (54)

1. Abrami L, Bischofberger M, Kunz B, Groux R, van der Goot FG. 2010. Endocytosis of the anthrax toxin is mediated by clathrin, actin and unconventional adaptors. PLoS Pathog. 6:e1000792.
2. Brown D, Hasler U, Nunes P, Bouley R, Lu HA. 2008. Phosphorylation events and the modulation of aquaporin 2 cell surface expression. Curr. Opin. Nephrol. Hypertens. 17:491-498.
3. Carroll SF, Barbieri JT, Collier RJ. 1988. Diphtheria toxin: purification and properties. Methods Enzymol. 165:68 -76.
4. Chand HS, et al. 2008. Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model. Infect. Immun. 77:429-435.
5. Collier RJ. 1975. Diphtheria toxin: mode of action and structure. Bacteriol. Rev. 39:54-85.
6. Comer JE, et al. 2006. Murine macrophage transcriptional and functional responses to Bacillus anthracis edema toxin. Microb. Pathog. 41:96 -110.
7. Cui X, et al. 2007. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J. Infect. Dis. 195:572-580.
8. Dumetz F, et al. 2011. Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am. J. Pathol. 178:2523-2535.
9. Eto K, Noda Y, Horikawa S, Uchida S, Sasaki S. 2010. Phosphorylation of aquaporin-2 regulates its water permeability. J. Biol. Chem. 285:40777-40784.
10. Fenton RA, Moeller HB. 2008. Recent discoveries in vasopressinregulated aquaporin-2 trafficking. Prog. Brain Res. 170:571-579.
11. Fenton RA, et al. 2008. Acute regulation of aquaporin-2 phosphorylation at Ser-264 by vasopressin. Proc. Natl. Acad. Sci. U. S. A. 105:3134 -3139.
12. Firoved AM, et al. 2005. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167:1309 -1320.
13. Firoved AM, et al. 2007. Anthrax edema toxin sensitizes DBA/2J mice to lethal toxin. Infect. Immun. 75:2120 -2125.
14. Guichard A, et al. 2010. Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst. Nature 467:854-858.
15. Hong J, et al. 2007. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J. Biol. Chem. 282:19781-19787.
16. Hozawa S, Holtzman EJ, Ausiello DA. 1996. cAMP motifs regulating transcription in the aquaporin 2 gene. Am. J. Physiol. 270:C1695-C1702.
17. Klussmann E, et al. 2001. An inhibitory role of Rho in the vasopressinmediated translocation of aquaporin-2 into cell membranes of renal principal cells. J. Biol. Chem. 276:20451-20457.
18. Labruyere E, et al. 1991. Structural and ligand-binding properties of a truncated form of Bacillus anthracis adenylate cyclase and of a catalytically inactive variant in which glutamine substitutes for lysine-346. Biochemistry 30:2619 -2624.
19. Leppla SH. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. U. S. A. 79:3162-3166.
20. Liu S, et al. 2009. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc. Natl. Acad. Sci. U. S. A. 106:12424 -12429.
21. Liu S, Leppla SH. 2003. Retroviral insertional mutagenesis identifies a small protein required for synthesis of diphthamide, the target of bacterial ADP-ribosylating toxins. Mol. Cell 12:603-613.
22. Liu S, et al. 2010. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe 8:455-462.
23. Mabry R, et al. 2006. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin. Vaccine Immunol. 13:671-677.
24. Makino S, Watarai M, Cheun HI, Shirahata T, Uchida I. 2002. Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax. J. Infect. Dis. 186:227-233.
25. Maldonado-Arocho FJ, Fulcher JA, Lee B, Bradley KA. 2006. Anthrax oedema toxin induces anthrax toxin receptor expression in monocytederived cells. Mol. Microbiol. 61:324 -337.
26. Matsumura Y, Uchida S, Rai T, Sasaki S, Marumo F. 1997. Transcriptional regulation of aquaporin-2 water channel gene by cAMP. J. Am. Soc. Nephrol. 8:861-867.
27. Milne JC, Furlong D, Hanna PC, Wall JS, Collier RJ. 1994. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J. Biol. Chem. 269:20607-20612.
28. Moayeri M, et al. 2010. Inflammasome sensor Nlrp1b-dependent resistance to anthrax Is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog. 6:e1001222.
29. Moayeri M, Leppla SH. 2009. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol. Aspects Med. 30:439-455.
30. Moayeri M, Wiggins JF, Leppla SH. 2007. Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect. Immun. 75:5175-5184.
31. Moayeri M, Wiggins JF, Lindeman RE, Leppla SH. 2006. Cisplatin inhibition of anthrax lethal toxin. Antimicrob. Agents Chemother. 50: 2658-2665.
32. Moeller HB, Praetorius J, Rutzler MR, Fenton RA. 2010. Phosphorylation of aquaporin-2 regulates its endocytosis and protein-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 107:424-429.
33. Molnar DM, Altenbern RA. 1963. Alterations in the biological activity of protective antigen of Bacillus anthracis toxin. Proc. Soc. Exp. Biol. Med. 114:294 -297.
34. Morris RE, Gerstein AS, Bonventre PF, Saelinger CB. 1985. Receptormediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect. Immun. 50:721-727.
35. Naglich JG, Metherall JE, Russell DW, Eidels L. 1992. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGFlike growth factor precursor. Cell 69:1051-1061.
36. Nielsen S, DiGiovanni SR, Christensen EI, Knepper MA, Harris HW. 1993. Cellular and subcellular immunolocalization of vasopressinregulated water channel in rat kidney. Proc. Natl. Acad. Sci. U. S. A. 90: 11663-11667.
37. Noda Y, Sasaki S. 2005. Trafficking mechanism of water channel aquaporin-2. Biol. Cell 97:885-892.
38. Paccani SR, et al. 2007. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signaling. Cell. Microb. 9:924 -929.
39. Park S, Leppla SH. 2000. Optimized production and purification of Bacillus anthracis lethal factor. Protein Expr. Purif. 18:293-302.
40. Pezard C, Berche P, Mock M. 1991. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59:3472-3477.
41. Poggesi I, et al. 2009. Pharmacokinetics in special populations. Drug Metab. Rev. 41:422-454.
42. Preston GM, Agre P. 1991. Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. Proc. Natl. Acad. Sci. U. S. A. 88:11110 -11114.
43. Puhar A, Dal Molin F, Horvath S, Ladant D, Montecucco C. 2008. Anthrax edema toxin modulates PKA and CREB dependent signaling in two phases. PLoS One 3:e3564.
44. Roberts JA, Lipman J. 2009. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit. Care Med. 37:840-851.
45. Schrier RW, Wang W. 2004. Acute renal failure and sepsis. N. Engl. J. Med. 351:159 -169.
46. Seamon KB, Daly JW. 1981. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7:201-224.
47. Simpson JC, Smith DC, Roberts LM, Lord JM. 1998. Expression of mutant dynamin protects cells against diphtheria toxin but not against ricin. Exp. Cell Res. 239:293-300.
48. Smith H, Keppie J, Stanley JL. 1955. The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. anthracis in vivo. Br. J. Exp. Pathol. 36:460-472.
49. Soelaiman S, et al. 2003. Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough. J. Biol. Chem. 278:25990 -25997.
50. Tajika Y, et al. 2004. Aquaporin-2 is retrieved to the apical storage compartment via early endosomes and phosphatidylinositol 3-kinasedependent pathway. Endocrinology 145:4375-4383.
51. Tang S, et al. 2009. Detection of anthrax toxin by an ultrasensitive immunoassay using Europium nanoparticles. Clin. Vaccine Immunol. 16: 408-413.
52. Tournier JN, Rossi PS, Quesnel-Hellmann A, Baldari CT. 2009. Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Mol. Aspects Med. 30:456-466.
53. Uchida I, et al. 1993. Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis. Mol. Microbiol. 9:487-496.
54. Yeager LA, Chopra AK, Peterson JW. 2009. Bacillus anthracis edema toxin suppresses human macrophage phagocytosis and cytoskeletal remodeling via the protein kinase A and exchange protein activated by cyclic AMP pathways. Infect. Immun. 77:2530 -2543.